| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0689a977285005ea7500fc8bd0ba7c3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2471 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C21-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C21-02 |
| filingDate |
2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65747c489bf863492cc86f782ca93be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4335df712b0d449d6b81094d1f56caff |
| publicationDate |
2022-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4101303-A1 |
| titleOfInvention |
Galactooligosaccharides with a dp greater than 6 |
| abstract |
Proposed are galactooligosaccharides with a DP greater than 6 obtained or obtainable by the following steps: (i) providing an aqueous lactose solution; (ii) sterilization of the lactose solution; (iii) transgalactosylation of the lactose present in the sterilized lactose solution from step (ii) while adding a first beta-galactosidase within its optimal temperature and pH range for a period of at least 30 minutes to obtain a first reaction mixture; (iv) inhibition of enzyme bulk in the reaction mixture of step (iii) (v) transgalactosylation of the reaction solution from step (iv)) with addition of a second beta-galactosidase within its optimal temperature and pH range for a period of at least 30 minutes to obtain a second reaction mixture; (vi) inhibition of enzyme bulk in the reaction mixture of step (v), and (vii) formulation of the reaction mixture from step (vi). |
| priorityDate |
2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |